(Q46418288)

22 December 2017

title

Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia (English)

1 reference

22 December 2017

1 reference

11

1 reference

22 December 2017

Benedikt Brors

object named as

Benedikt Brors

10

0 references

Norbert Gattermann

14

object named as

Norbert Gattermann

1 reference

22 December 2017

author name string

Ralf Kronenwett

1

1 reference

22 December 2017

Ulf Butterweck

2

1 reference

22 December 2017

Ulrich Steidl

3

1 reference

22 December 2017

Slawomir Kliszewski

4

1 reference

22 December 2017

Frank Neumann

5

1 reference

22 December 2017

Simone Bork

6

1 reference

22 December 2017

Elena Diaz Blanco

7

1 reference

22 December 2017

Nicole Roes

8

1 reference

22 December 2017

Thorsten Gräf

9

1 reference

22 December 2017

Christian Maercker

12

1 reference

22 December 2017

Guido Kobbe

13

1 reference

22 December 2017

Rainer Haas

15

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

22 December 2017

published in

Oncogene

1 reference

22 December 2017

volume

24

1 reference

22 December 2017

issue

34

1 reference

22 December 2017

page(s)

5313-5324

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208596

exact match

0 references

cites work

The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

The biology of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph1-positive chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

MyD genes in negative growth control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Chronic myelogenous leukemia molecular signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Molecular biology of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Getting the right cells to the array: Gene expression microarray analysis of cell mixtures and sorted cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Guidelines for human gene nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Hematopoietic cytokines, transcription factors and lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

7 January 2021

Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

7 January 2021

ETV6 gene rearrangements in hematopoietic malignant disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208596

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208596

1 reference

22 December 2017

PubMed ID

15806158

1 reference

22 December 2017